Global Nasal Spray Market Growth to surge with Increasing Adoption due to Easy Administration Methods
Inkwood Research estimates that the Global Nasal Spray Market is evaluated to register a CAGR of 9.39% in terms of revenue during the forecasting years of 2021-2028.
“Browse 65 Market Data Tables and 54 Figures spread over 230
Pages, along with an in-depth TOC on the Global Nasal Spray Market Forecast 2021-2028.”
REQUEST FREE SAMPLE LINK - https://inkwoodresearch.com/reports/nasal-spray-market/#request-free-sample
VIEW TABLE OF
CONTENT LINK - https://inkwoodresearch.com/reports/nasal-spray-market/#table-of-contents
BUY NOW- https://inkwoodresearch.com/reports/nasal-spray-market/
Nasal sprays are liquid medicines sprayed into the nose.
They are of different types and help in tackling allergies. They are available
either as prescriptions or over the counter. They come in two forms, pump and
regular.
Rising
Adoption of Nasal Sprays drives Market Growth
Intranasal administration minimizes the possibility of
systemic adverse effects and medication interactions. Medication is
administered directly through a nasal spray to the site of allergic irritation.
Also, a nasal spray is considered a gentle, non-invasive, and promising
alternative. The nasal mucosa is very immunocompetent due to its regular
exposure to microorganisms and dust. Moreover, intranasal vaccination offers
wider protection, given the presence of nasal-associated lymphoid tissue
(NALT).
Furthermore, intranasal administration induces systemic
immunity and mucosal (protection at the site of infection). This includes the
activation of circulating immune cells and antibody formation. Also, the nasal
route offers cross-protection against virus strains like influenza. In
addition, nasal sprays are cost-effective and easy-to-use solutions, and hence,
are being increasingly preferred by patients worldwide.
To know more about this report, request
a free sample copy.
Major
Product: Decongestion Nasal Spray
A decongestion nasal spray offers temporary relief from nasal
congestion caused due to allergies, hay fever, sinusitis, and the common cold.
Also, it shrinks swollen tissues and blood vessels that cause congestion.
Phenylephrine hydrochloride (Neo-Synephrine) and oxymetazoline hydrochloride
(Afrin, Dristan, Sinex) are examples of decongestion nasal sprays.
Highest Revenue
Share: North America
North America is witnessing increasing cases of allergic
rhinitis and infections. Also, the trends like painless drug administration,
growing pollution rates, increasing geriatric population, rising patient
compliance, and changing lifestyles are the additional key drivers of market
growth in the region. Moreover, nasal spray adoption as an efficient drug
administration route, coupled with the rising demand for self-administration,
offers ample market growth opportunities.
The strong competitive space is created by companies with
larger product portfolios and undifferentiated products. Also, these companies
are investing heavily in R&D and expanding their facilities. Pfizer Inc,
Johnson & Johnson, Proctor & Gamble Co, Sun Pharmaceuticals Industries
Ltd, GlaxoSmithKline Plc, etc., are among the major firms in the market.
About Inkwood
Research
Inkwood Research specializes in syndicated & customized
research reports and consulting services. Market intelligence studies with
relevant fact-based research are customized across industry verticals such as
technology, automotive, chemicals, materials, healthcare, and energy, with an
objective comprehension that acknowledges the business environments. Our
geographical analysis comprises North & South America, CEE, CIS, Middle
East, Europe, Asia, and Africa.
Contact Us
https://www.inkwoodresearch.com
+1 857-302-4704
Related Reports:
Comments
Post a Comment